Structure Therapeutics (GPCR) Earnings Date & Reports

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GPCR is expected to report earnings to rise 8.57% to -37 cents per share on November 18

Structure Therapeutics GPCR Stock Earnings Reports

Q3'26

Est.

$-0.38

Q1'26

Est.

$-0.35

Q4'25

Beat

by $0.45

Q3'25

Missed

by $0.10

Q2'25

Missed

by $0.10

The last earnings report on May 07 showed earnings per share of -34 cents, meeting the estimate of -34 cents. With 341.67K shares outstanding, the current market capitalization sits at 3.50B.

View a ticker or compare two or three

GPCR

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days